Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Non Randomized Monocentric Phase I Study Evaluation the Pharmacokinetic Profile of Novel Formulations of RHUDEX®

NCT01500122 is registered in ClinicalTrials.gov with MediGene as lead sponsor.

NCT NCT01500122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Non Randomized Monocentric Phase I Study Evaluation the Pharmacokinetic Profile of Novel Formulations of RHUDEX®
Lead sponsor
MediGene
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2011
Completion date
June 30, 2012
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

formulation finding